|
BRIDGING THE GAP FROM GENES TO CIRCUITS TO BEHAVIOR IN UNDERSTANDING COGNITIVE DYSFUNCTION |
1DP2AG058487-01 |
RAJASETHUPATHY, PRIYA |
NIA |
2017 |
|
METABOLIC MECHANISMS FOR TREATING COGNITIVE AGING |
1F31AG058455-01 |
HERNANDEZ, ABIGAIL LYNN |
NIA |
2017 |
|
A PERIPHERAL ROUTE FOR GUT TO BRAIN PROPAGATION OF PATHOLOGIC ALPHA-SYNUCLEIN IN PARKINSON'S DISEASE |
1F32AG054101-01A1 |
CHALLIS, COLLIN M |
NIA |
2017 |
|
ESTRADIOL REDUCES MITOCHONDRIAL OXIDANT STRESS IN SNC DA NEURONS |
1F32AG058396-01 |
STOUT, KRISTEN |
NIA |
2017 |
|
RECEPTOR-MEDIATED CLEARANCE OF SYNAPTIC TAU AS A NOVEL THERAPY FOR ALZHEIMER'S DISEASE. |
1K01AG055694-01 |
MYEKU, NATURA |
NIA |
2017 |
|
A MOLECULAR SIGNALING PATHWAY UNDERLYING DIFFERENTIAL PREDISPOSITION OF APOE4 GENOTYPE TO ALZHEIMER'S DISEASE |
1K99AG054616-01 |
HUANG, YU-WEN ALVIN |
NIA |
2017 |
|
THE ROLE OF EPIGENETICS IN AGE-RELATED COGNITIVE DECLINE AND ALZHEIMER'S DISEASE |
1K99AG055683-01 |
ROSS, JAIME MARIE |
NIA |
2017 |
|
COMPARATIVE GENOMIC APPROACHES TO IMPROVE IPSC-DERIVED MOTOR NEURON MODELS OF ALS |
1K99AG056678-01 |
HO, RITCHIE |
NIA |
2017 |
|
ROLE OF BETA-ADRENERGIC RECEPTORS IN MODULATION OF COGNITION AND CENTRAL AND PERIPHERAL IMMUNE SYSTEMS IN ALZHEIMER'S DISEASE |
1R01AG054533-01A1 |
SHAMLOO, MEHRDAD |
NIA |
2017 |
|
ACE2 AS A NOVEL THERAPEUTIC TO PRESERVE PHYSICAL FUNCTION IN LATE LIFE |
1R01AG054538-01A1 |
BUFORD, THOMAS W |
NIA |
2017 |